Captrust Financial Advisors Galapagos Nv Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $8,108 - $10,823	158 Added 71.82%	378 $23,000
Q3 2021 Nov 16, 2021	SELL	$52.17 - $70.2 $2,504 - $3,369	-48 Reduced 17.91%	220 $12,000
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $2,892 - $3,500	42 Added 18.58%	268 $18,000
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $456 - $671	6 Added 2.73%	226 $17,000
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $17,433 - $26,685	180 Added 450.0%	220 $22,000
Q3 2020 Nov 17, 2020	BUY	$122.47 - $213.56 $4,898 - $8,542	40 New	40 $6,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.